image
Healthcare - Medical - Devices - NASDAQ - US
$ 260.12
-0.398 %
$ 18.2 B
Market Cap
44.24
P/E
1. INTRINSIC VALUE

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.[ Read More ]

The intrinsic value of one PODD stock under the base case scenario is HIDDEN Compared to the current market price of 260 USD, Insulet Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart PODD

image
FINANCIALS
1.7 B REVENUE
30.02%
220 M OPERATING INCOME
923.97%
206 M NET INCOME
4384.78%
146 M OPERATING CASH FLOW
22.44%
-119 M INVESTING CASH FLOW
37.52%
-13.6 M FINANCING CASH FLOW
66.25%
373 M REVENUE
-23.73%
88.1 M OPERATING INCOME
61.36%
77.5 M NET INCOME
-58.91%
98.5 M OPERATING CASH FLOW
2.07%
-29.3 M INVESTING CASH FLOW
-17.67%
7.8 M FINANCING CASH FLOW
966.67%
Balance Sheet Decomposition Insulet Corporation
image
Current Assets 1.58 B
Cash & Short-Term Investments 704 M
Receivables 360 M
Other Current Assets 519 M
Non-Current Assets 1.01 B
Long-Term Investments 26.6 M
PP&E 693 M
Other Non-Current Assets 286 M
Current Liabilities 451 M
Accounts Payable 19.2 M
Short-Term Debt 52.9 M
Other Current Liabilities 379 M
Non-Current Liabilities 1.4 B
Long-Term Debt 1.4 B
Other Non-Current Liabilities 8.4 M
EFFICIENCY
Earnings Waterfall Insulet Corporation
image
Revenue 1.7 B
Cost Of Revenue 537 M
Gross Profit 1.16 B
Operating Expenses 940 M
Operating Income 220 M
Other Expenses 13.7 M
Net Income 206 M
RATIOS
68.35% GROSS MARGIN
68.35%
12.96% OPERATING MARGIN
12.96%
12.16% NET MARGIN
12.16%
28.16% ROE
28.16%
7.97% ROA
7.97%
9.83% ROIC
9.83%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Insulet Corporation
image
Net Income 206 M
Depreciation & Amortization 72.8 M
Capital Expenditures -75.6 M
Stock-Based Compensation 48.3 M
Change in Working Capital -191 M
Others 37.1 M
Free Cash Flow 36.5 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Insulet Corporation
image
Wall Street analysts predict an average 1-year price target for PODD of $247 , with forecasts ranging from a low of $200 to a high of $300 .
PODD Lowest Price Target Wall Street Target
200 USD -23.11%
PODD Average Price Target Wall Street Target
247 USD -5.15%
PODD Highest Price Target Wall Street Target
300 USD 15.33%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Insulet Corporation
image
Sold
0-3 MONTHS
4.28 M USD 6
3-6 MONTHS
2.7 M USD 3
6-9 MONTHS
1.89 M USD 1
9-12 MONTHS
5.78 M USD 2
Bought
20.6 K USD 1
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
5 days ago
Nov 12, 2024
Sell 140 K USD
BORIO LUCIANA
Director
- 508
274.8 USD
2 months ago
Sep 11, 2024
Sell 1.72 M USD
Hopfield Jessica
Director
- 7628
225.26 USD
2 months ago
Sep 10, 2024
Sell 1.13 M USD
Scannell Timothy J
Director
- 5000
225.84 USD
2 months ago
Sep 09, 2024
Sell 305 K USD
Field Mark N
SVP & Chief Technology Officer
- 1383
220.87 USD
2 months ago
Sep 09, 2024
Sell 333 K USD
Budden Lauren
Group VP, CAO and Controller
- 1506
221.41 USD
2 months ago
Aug 30, 2024
Sell 369 K USD
Singh Prem
SVP, Global Operations
- 1824
202.27 USD
2 months ago
Aug 29, 2024
Bought 20.6 K USD
Chadwick Ana Maria
EVP, CFO & Treasurer
+ 100
206 USD
2 months ago
Aug 28, 2024
Sell 282 K USD
Field Mark N
SVP & Chief Technology Officer
- 1387
203 USD
5 months ago
Jun 14, 2024
Sell 300 K USD
Field Mark N
SVP & Chief Technology Officer
- 1500
199.96 USD
5 months ago
Jun 10, 2024
Sell 1.33 M USD
Scannell Timothy J
Director
- 7000
190.51 USD
5 months ago
Jun 10, 2024
Sell 406 K USD
Field Mark N
SVP & Chief Technology Officer
- 2131
190.43 USD
5 months ago
Jun 04, 2024
Sell 65.7 K USD
BORIO LUCIANA
Director
- 360
182.58 USD
5 months ago
May 28, 2024
Sell 597 K USD
Scannell Timothy J
Director
- 3300
180.9 USD
8 months ago
Feb 28, 2024
Sell 1.89 M USD
Petrovic Shacey
Director
- 11609
162.92 USD
11 months ago
Dec 15, 2023
Sell 14.9 K USD
BORIO LUCIANA
Director
- 72
207.08 USD
1 year ago
Nov 13, 2023
Sell 342 K USD
Petrovic Shacey
Director
- 2075
165.02 USD
1 year ago
Nov 13, 2023
Sell 3.29 M USD
Petrovic Shacey
Director
- 20000
164.33 USD
1 year ago
Nov 13, 2023
Sell 2.13 M USD
Petrovic Shacey
Director
- 12925
165.02 USD
1 year ago
Sep 19, 2023
Bought 169 USD
Singh Prem
SVP, Global Operations
+ 1
168.92 USD
1 year ago
Aug 28, 2023
Bought 1.01 M USD
Hollingshead James
President and CEO
+ 5550
181.41 USD
1 year ago
Jul 03, 2023
Sell 393 K USD
McMillan Wayde D.
EVP, CFO
- 1388
282.94 USD
1 year ago
Jun 20, 2023
Sell 50.8 K USD
Manea Dan
SVP, Chief HR Officer
- 175
290 USD
1 year ago
Jun 05, 2023
Sell 142 K USD
BORIO LUCIANA
Director
- 500
283.38 USD
1 year ago
Jun 01, 2023
Sell 4.07 M USD
Petrovic Shacey
Director
- 15000
271.56 USD
1 year ago
May 23, 2023
Bought 1.01 M USD
MINOGUE MICHAEL R
Director
+ 3300
304.75 USD
1 year ago
Apr 03, 2023
Sell 399 K USD
McMillan Wayde D.
EVP, CFO
- 1255
318.31 USD
1 year ago
Mar 13, 2023
Sell 7.14 M USD
Alpuche Charles
Advisor
- 23401
305.15 USD
1 year ago
Mar 09, 2023
Sell 1.16 M USD
Alpuche Charles
Advisor
- 4000
290.9 USD
1 year ago
Feb 28, 2023
Sell 1.06 M USD
Alpuche Charles
Advisor
- 3800
278.81 USD
1 year ago
Feb 28, 2023
Sell 55.8 K USD
Alpuche Charles
Advisor
- 200
279.01 USD
1 year ago
Mar 01, 2023
Sell 4.15 M USD
Petrovic Shacey
Advisor
- 15000
276.63 USD
1 year ago
Jan 04, 2023
Sell 4.23 M USD
Petrovic Shacey
Director
- 15000
281.88 USD
1 year ago
Jan 03, 2023
Sell 389 K USD
McMillan Wayde D.
EVP, CFO
- 1359
286.43 USD
2 years ago
Nov 18, 2022
Sell 58.9 K USD
Manea Dan
SVP, Chief HR Officer
- 200
294.62 USD
2 years ago
Nov 18, 2022
Sell 885 K USD
Christensen Bret
EVP and CCO
- 3000
295.15 USD
2 years ago
Nov 04, 2022
Sell 4.22 M USD
Spears Michael P
SVP, RA and Compliance
- 13658
308.99 USD
2 years ago
Oct 03, 2022
Sell 3.48 M USD
Petrovic Shacey
Director
- 15000
231.8 USD
2 years ago
Aug 24, 2022
Sell 766 K USD
Christensen Bret
EVP and CCO
- 2900
264.24 USD
2 years ago
Jul 01, 2022
Sell 3.34 M USD
Petrovic Shacey
director:
- 15000
222.9 USD
2 years ago
Jun 06, 2022
Sell 1.29 M USD
Alpuche Charles
EVP & Chief Operating Officer
- 6000
215.32 USD
2 years ago
Mar 17, 2022
Sell 4.1 M USD
Petrovic Shacey
President and CEO
- 15000
273.25 USD
2 years ago
Apr 01, 2022
Sell 401 K USD
McMillan Wayde D.
EVP, CFO
- 1455
275.6 USD
2 years ago
Jan 05, 2022
Sell 3.97 M USD
Petrovic Shacey
President and CEO
- 15000
264.97 USD
2 years ago
Dec 31, 2021
Sell 51.4 K USD
McMillan Wayde D.
EVP, CFO
- 193
266.37 USD
2 years ago
Dec 31, 2021
Sell 107 K USD
McMillan Wayde D.
EVP, CFO
- 400
267.82 USD
2 years ago
Dec 31, 2021
Sell 134 K USD
McMillan Wayde D.
EVP, CFO
- 500
268.88 USD
2 years ago
Dec 31, 2021
Sell 182 K USD
McMillan Wayde D.
EVP, CFO
- 672
270.19 USD
2 years ago
Dec 31, 2021
Sell 24.4 K USD
McMillan Wayde D.
EVP, CFO
- 90
271.23 USD
3 years ago
Nov 11, 2021
Sell 1.44 M USD
Lemoine David A
Director
- 4565
314.96 USD
3 years ago
Oct 01, 2021
Sell 4.24 M USD
Petrovic Shacey
President and CEO
- 15000
282.87 USD
3 years ago
Aug 26, 2021
Sell 882 K USD
Christensen Bret
EVP and CCO
- 3000
294.13 USD
3 years ago
Aug 17, 2021
Sell 1.2 M USD
Alpuche Charles
EVP & Chief Operating Officer
- 4000
300.44 USD
3 years ago
Aug 09, 2021
Sell 357 K USD
Lemoine David A
Director
- 1286
277.48 USD
3 years ago
Jul 01, 2021
Sell 627 K USD
Alpuche Charles
EVP & Chief Operating Officer
- 2250
278.67 USD
3 years ago
Jul 01, 2021
Sell 4.18 M USD
Petrovic Shacey
President and CEO
- 15000
278.56 USD
3 years ago
Jun 04, 2021
Sell 2.69 M USD
CRAWFORD SALLY
Director
- 10000
269.075 USD
3 years ago
Jun 02, 2021
Sell 499 K USD
Alpuche Charles
EVP & Chief Operating Officer
- 1900
262.67 USD
3 years ago
May 21, 2021
Sell 567 K USD
Fallon John A.
Director
- 2235
253.6055 USD
3 years ago
May 21, 2021
Sell 908 K USD
Fallon John A.
Director
- 3587
253.205 USD
3 years ago
May 13, 2021
Sell 216 K USD
Nevinny Corinne H
Director
- 933
231.42 USD
3 years ago
Apr 01, 2021
Sell 3.99 M USD
Petrovic Shacey
President and CEO
- 15000
266.17 USD
3 years ago
Jan 04, 2021
Sell 3.76 M USD
Petrovic Shacey
President and CEO
- 15000
250.61 USD
4 years ago
Nov 17, 2020
Sell 251 K USD
Lemoine David A
Director
- 1000
250.71 USD
4 years ago
Nov 04, 2020
Sell 690 K USD
Fallon John A.
Director
- 3000
230 USD
4 years ago
Nov 02, 2020
Sell 900 K USD
Fallon John A.
Director
- 4000
225 USD
4 years ago
Oct 09, 2020
Sell 5.48 M USD
Spears Michael P
SVP, RA and Compliance
- 22257
246.1 USD
4 years ago
Oct 05, 2020
Sell 3.51 M USD
Petrovic Shacey
President and CEO
- 15000
233.91 USD
4 years ago
Sep 01, 2020
Sell 752 K USD
Alpuche Charles
EVP & Chief Operating Officer
- 3415
220.11 USD
4 years ago
Aug 12, 2020
Sell 1.01 M USD
Christensen Bret
EVP and CCO
- 5000
201.54 USD
4 years ago
Jul 23, 2020
Sell 1.76 M USD
Benjamin Eric
SVP, Innovation and Strategy
- 8392
210 USD
4 years ago
Apr 30, 2020
Sell 156 K USD
Nevinny Corinne H
Director
- 796
195.54 USD
4 years ago
May 01, 2020
Sell 170 K USD
Nevinny Corinne H
Director
- 863
196.82 USD
4 years ago
Apr 16, 2020
Sell 281 K USD
Spears Michael P
SVP, RA and Compliance
- 1449
193.76 USD
4 years ago
Mar 06, 2020
Sell 185 K USD
Lemoine David A
Director
- 1042
177.49 USD
4 years ago
Feb 27, 2020
Sell 2.48 M USD
Spears Michael P
SVP, RA and Compliance
- 13627
182.0059 USD
4 years ago
Feb 28, 2020
Sell 126 K USD
Spears Michael P
SVP, RA and Compliance
- 664
190 USD
4 years ago
Jan 02, 2020
Sell 2.12 M USD
Petrovic Shacey
President and CEO
- 12500
169.6298 USD
4 years ago
Jan 02, 2020
Sell 494 K USD
Lemoine David A
Director
- 2884
171.24 USD
5 years ago
Nov 15, 2019
Sell 900 K USD
Fallon John A.
Director
- 5000
180.065 USD
5 years ago
Nov 18, 2019
Sell 1.73 M USD
Fallon John A.
Director
- 9525
181.4087 USD
5 years ago
Nov 01, 2019
Sell 100 K USD
Petrovic Shacey
President and CEO
- 689
145.69 USD
5 years ago
Sep 03, 2019
Sell 98.9 K USD
Petrovic Shacey
President and CEO
- 649
152.4 USD
5 years ago
Aug 15, 2019
Sell 607 K USD
Spears Michael P
SVP, RA and Compliance
- 4153
146.12 USD
5 years ago
Jun 05, 2019
Sell 101 K USD
Petrovic Shacey
President and CEO
- 895
113 USD
5 years ago
May 31, 2019
Sell 3.08 M USD
CRAWFORD SALLY
Director
- 28347
108.6 USD
5 years ago
May 15, 2019
Sell 89.6 K USD
Lemoine David A
Director
- 874
102.49 USD
5 years ago
May 16, 2019
Sell 936 K USD
Lemoine David A
Director
- 8752
106.9192 USD
5 years ago
May 15, 2019
Sell 409 K USD
Alpuche Charles
EVP & Chief Operating Officer
- 3900
104.7825 USD
5 years ago
Apr 02, 2019
Sell 702 K USD
Colleran David
SVP, Secretary and GC
- 7395
94.89 USD
5 years ago
Mar 20, 2019
Sell 500 K USD
Fallon John A.
Director
- 5000
100 USD
5 years ago
Mar 12, 2019
Sell 2.57 M USD
Abdel-Malek Aiman
EVP & Chief Technology Officer
- 27349
94.0295 USD
7. News
Insulet to Present at Upcoming Investor Conferences ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at three upcoming investor conferences (all Eastern Time): The 6th Annual Wolfe Research Healthcare Conference in New York City on Wednesday, November 20, 2024 at 12:00 p.m. The Nasdaq 51st Investor Conference in London on Tuesday, December 10, 2024 at 5:30 a.m. The J.P. Morgan 43rd An. businesswire.com - 2 days ago
Buy Profitable S&P 500 Stocks as the Index Tops 6000: NVIDIA & 2 More NVIDIA, Insulet and Howmet Aerospace have been selected as the top picks with a high net income ratio. zacks.com - 4 days ago
Why Insulet (PODD) is a Top Growth Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. zacks.com - 4 days ago
PODD Stock Gains on Q3 Earnings and Revenue Beat, '24 Sales View Up Insulet's third-quarter performance benefits from the continued high demand for Omnipod 5. zacks.com - 4 days ago
Insulet CEO on earnings, GLP-1 and election impact Jim Hollingshead, Insulet CEO, joins 'Closing Bell: Overtime' to discuss the Insulet earnings, Apple blood sugar testing app and more. youtube.com - 5 days ago
Buy, Sell, Or Hold Insulet (PODD) Stock? Insulet stock (NASDAQ: PODD) surged nearly 10% on Friday, November 8, after the company posted an upbeat Q3 and raised its sales outlook. It reported sales of $544 million and adjusted earnings of $0.90 per share, compared to the consensus estimates of $518 million and $0.77, respectively. forbes.com - 5 days ago
Insulet Corporation (PODD) Q3 2024 Earnings Call Transcript Insulet Corporation (PODD) Q3 2024 Earnings Call Transcript seekingalpha.com - 1 week ago
Insulet (PODD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates Although the revenue and EPS for Insulet (PODD) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 1 week ago
Insulet (PODD) Q3 Earnings and Revenues Top Estimates Insulet (PODD) came out with quarterly earnings of $0.90 per share, beating the Zacks Consensus Estimate of $0.77 per share. This compares to earnings of $0.71 per share a year ago. zacks.com - 1 week ago
Insulet raises annual revenue forecast on strong demand for insulin pumps Insulet raised its annual revenue growth forecast on Thursday, banking on strong demand for its wearable insulin pumps. reuters.com - 1 week ago
Insulet Stock Gains From Expansion Strategies, Innovation PODD continues to drive increased awareness for Omnipod through its direct-to-consumer advertising campaign. zacks.com - 1 week ago
Stay Ahead of the Game With Insulet (PODD) Q3 Earnings: Wall Street's Insights on Key Metrics Get a deeper insight into the potential performance of Insulet (PODD) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. zacks.com - 1 week ago
8. Profile Summary

Insulet Corporation PODD

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 18.2 B
Dividend Yield 0.00%
Description Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Contact 100 Nagog Park, Acton, MA, 01720 https://www.insulet.com
IPO Date May 15, 2007
Employees 3000
Officers Dr. James R. Hollingshead Ph.D. President, Chief Executive Officer & Director Ms. Lauren Budden Group Vice President, Chief Accounting Officer & Controller Mr. Mark Field Senior Vice President & Chief Technology Officer Mr. Eric Benjamin Executive Vice President, Chief Product & Customer Experience Officer Mr. Philip Hildale Senior Vice President of Sales & Customer Care Ms. Ana Maria Chadwick Executive Vice President, Chief Financial Officer & Treasurer Mr. Prem Singh Senior Vice President of Global Operations Ms. Deborah R. Gordon CPA Vice President of Investor Relations Ms. Laetitia Cousin Senior Vice President of Regulatory Affairs, Quality Assurance & Compliance Angela Geryak Wiczek Senior Director of Corporate Communications